Capecitabine In Combination With Cemiplimab In Patient With Metastatic Breast Cancer

Clinical trial NCT05064085 · COMPLETED

Trial details

NCT number: NCT05064085
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hormone Receptor-positive Breast Cancer

Start date: 2021-10-12
Primary completion: 2024-09-09
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.